The value of DNA repair gene and TP53 co-mutation in predicting the response of non-small cell lung cancer to immunotherapy [0.03%]
DNA修复基因和TP53突变联合预测非小细胞肺癌免疫治疗疗效价值的研究
Bin Ye,Chunzhi Wu,Xiaoying Quan et al.
Bin Ye et al.
Background: While mutations in DNA repair gene (DDR) or TP53 alone have been linked to favorable outcomes in immunotherapy, their co-mutations may not have the same effect. The co-occurrence of DDR and TP53 mutations may ...
Persistence of severe global inequalities in the burden of pancreatic cancer: a cross-sectional study [0.03%]
全球胰腺癌负担严重不平等的持续存在：一项横断面研究
Xin Qing,Yini Liu,Chengwei Xia
Xin Qing
Gut microbiota centered approaches for breast cancer intervention leveraging probiotics and postbiotics [0.03%]
以益生菌和后生素为中心的肠道微生物疗法在乳腺癌防治中的应用研究
A S Arya,A Mythili
A S Arya
HSPA8 is a biomarker associated with prognosis and immunity in skin cutaneous melanoma [0.03%]
HSPA8是皮肤黑色素瘤预后和免疫相关的生物标志物
Weizheng Liang,Chenyang Hou,Fengxu Yan et al.
Weizheng Liang et al.
Dan Wang,Yuting Zhang,Yujie Wang
Dan Wang
Exploring metabolic dynamics of cancer metastasis through in vitro models [0.03%]
通过体外模型探索癌症转移的代谢动力学
Ranae Lindeque,Christiaan F Labuschagne
Ranae Lindeque
The potential of cytokine polymorphisms as biomarkers for oral squamous cell carcinoma: a systematic review [0.03%]
细胞因子多态性作为口腔鳞状细胞癌生物标志物的潜力：系统评价
Mvuyisi O M Mfengu,Constance R Sewani-Rusike,Hannibal T Musarurwa et al.
Mvuyisi O M Mfengu et al.
SEPT9 as a therapeutic target for enhancing radiotherapy efficacy in esophageal squamous cell carcinoma [0.03%]
靶向Sept9提高放射治疗食管鳞癌疗效
Mingdong Ren,Jie Tao,Qiaoyu Sun et al.
Mingdong Ren et al.
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, where radiotherapy is a key treatment modality. However, radioresistance significantly limits its efficacy, leading to treatment failure. Septi...
Exploring molecular mechanisms of radioactive iodine therapy in thyroid cancer using single-cell RNA sequencing data [0.03%]
利用单细胞RNA测序数据探索分化型甲状腺癌放射性碘治疗的分子机制
Lin Guo,Yiren Feng,Senhe Jiang et al.
Lin Guo et al.
Targeting shared mechanisms of cisplatin resistance and metastasis in lung cancer for novel therapeutic strategies [0.03%]
针对肺癌顺铂耐药和转移的共同机制开发新型治疗方法
Xiao Liang,Xiaoren Zhu,Yingying Zhang et al.
Xiao Liang et al.